Nephrocare acquires Assumption Dialysis Center assets in Philippines for PhP 75 million

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Nephrocare Health Services Ltd acquired dialysis center assets from Assumption Dialysis Center in the Philippines for PhP 75 million. The deal, executed on August 17, 2026, adds to the company's international footprint following a previous acquisition in Davao City. Both transactions are arm's length asset purchases with no special rights or related-party implications.

powered bylight_fuzz_icon
48146818

*this image is generated using AI for illustrative purposes only.

Nephrocare Health Services has expanded its presence in the Philippines with the acquisition of dialysis center assets from Assumption Dialysis Center. The company’s overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services Philippines Inc., entered into an Asset Transfer Agreement dated August 14, 2026, which was executed on August 17, 2026.

The total consideration for the transaction is PhP 75,000,000 (Philippine Pesos Seventy-Five Million Only). The acquired assets pertain to a dialysis center located at Daang Maharlika, Brgy. Bunga, Abuyog, Leyte, Philippines.

Transaction Details

This acquisition follows an earlier deal by Nephrocare Health Services to acquire assets of Juan Nephro Dialysis Center in Davao City for PhP 71.8 million, under an agreement dated August 12, 2026. The new deal with Assumption Dialysis Center is structured as an asset purchase rather than a share acquisition.

According to the disclosure made to stock exchanges under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, there are no special rights attached to the agreement, such as director appointments or subscription rights. The seller is not related to the promoter group or group companies of Nephrocare Health Services, meaning the transaction does not fall within the scope of related-party transactions and was executed at arm’s length.

Particulars Details
Purchaser Nephrocare Health Care Services Philippines Inc.
Seller Assumption Dialysis Center
Consideration PhP 75,000,000
Asset Location Abuyog, Leyte, Philippines
Agreement Date August 14, 2026
Execution Date August 17, 2026
Related Party? No

Regulatory Disclosure

Nephrocare Health Services Limited issued the disclosure pursuant to SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. The company confirmed that no shares were issued as part of this agreement, and no loan facilities were involved in the transaction structure.

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.98%+2.67%-0.32%+27.39%0.0%0.0%

How does the rapid succession of acquisitions in Leyte and Davao City impact Nephrocare's projected timeline for achieving profitability in its Philippine operations?

What are the specific operational synergies or cost-saving measures Nephrocare expects to realize by integrating these two newly acquired dialysis centers?

Given the asset-purchase structure, how will Nephrocare manage potential liabilities or legacy issues associated with the acquired facilities in Abuyog and Davao?

Nephrocare Health Services
View Company Insights
View All News
like19
dislike

Nephrocare Health Services schedules analyst meet for Aug 18 in Mumbai

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Nephrocare Health Services Limited has scheduled an investor conference for August 18, 2026, in Mumbai. The meeting will feature group and one-on-one sessions with analysts and institutional investors. Discussions will be restricted to publicly available information, with no UPSI intended to be shared.

powered bylight_fuzz_icon
48147414

*this image is generated using AI for illustrative purposes only.

Nephrocare Health Services will host an analyst and institutional investor meeting on August 18, 2026, at the Grand Hyatt in Mumbai. The company disclosed the schedule under Regulation 30(6) read with Schedule III of the SEBI Listing Regulations, 2015.

The conference is scheduled to begin at 11:00 am IST. Company officials will participate in both group and one-on-one sessions with market participants. The disclosure was issued by Kishore Kathri, Company Secretary and Head Legal, on August 13, 2026.

Meeting Details

The interaction is part of the company’s regular engagement with investors. Key details of the scheduled event are outlined below:

Parameter Details
Date August 18, 2026
Time 11:00 am IST onwards
Venue Grand Hyatt, Mumbai
Format Group / 1*1 Meeting
Conference Name MOSL Conference

Disclosure Compliance

Nephrocare Health Services stated that all discussions during the meet will be based on publicly available information. The company confirmed that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions.

The intimation is available on the company’s website. The disclosure noted that changes to the schedule may occur due to exigencies on the part of the host or the company.

Historical Stock Returns for Nephrocare Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+1.98%+2.67%-0.32%+27.39%0.0%0.0%

How might Nephrocare's strategic roadmap for renal care expansion discussed at the meeting influence its valuation multiples in the upcoming quarter?

What specific operational metrics or capacity utilization targets is management likely to highlight to justify future capital expenditure plans?

Could the insights shared regarding competitive positioning in the dialysis sector signal potential M&A activity or partnership opportunities in 2027?

Nephrocare Health Services
View Company Insights
View All News
like16
dislike

More News on Nephrocare Health Services

1 Year Returns:0.00%